| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|---|---|---|---|---|
| 11th September 2020 | Mark A Sirgo | 21,485 | Open or private purchase | $0.65 | $14,003.92 |
| 11th September 2020 | Mark A Sirgo | 77,000 | Open or private purchase | $0.68 | $52,360.00 |
| 10th September 2020 | Mark A Sirgo | 50,000 | Open or private purchase | $0.60 | $30,000.00 |
| 21st August 2020 | John Temperato | 70,000 | Open or private purchase | $0.69 | $48,300.00 |
| 20th August 2020 | Michael T. Constantino | 34,108 | Open or private purchase | $0.75 | $25,581.00 |
| 17th August 2020 | Mark A Sirgo | 100,000 | Open or private purchase | $0.56 | $56,000.00 |
| 17th August 2020 | John Temperato | 35,000 | Open or private purchase | $0.57 | $19,831.00 |
| 14th August 2020 | Mark A Sirgo | 115,000 | Open or private sale | $4.90 | $563,500.00 |
| 13th August 2020 | Mark A Sirgo | 85,000 | Open or private sale | $4.53 | $385,050.00 |
| 7th August 2020 | Mark A Sirgo | 4,000 | Exercise of derivative | $0.00 |
9 Meters Biopharma
Innovate Biopharmaceuticals, Inc. is a clinical-stage biopharm Pharmaceutical company. The company is founded by Jay P. Madan and Kendyle Woodard in 2012.
Ticker: INNT
Sector: Healthcare
Industry: Biotechnology
SEC Central Index Key (CIK): 1551986
Employees: 8
Exchange: NASDAQ
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
We weren't able to import Fundamental data from the SEC disclosure.
There were no Red Flags found
Fundamentals
We weren't able to import Fundamental data from the SEC disclosure.
News
Japanese fashionista aiming to put Filipino kids on runway to success
22nd September 2020
BlackRock, JPMorgan climate votes at odds as new rules loom
22nd September 2020
